CN105124088A - Maca tablet candy containing tagatose and Maca tablets - Google Patents
Maca tablet candy containing tagatose and Maca tablets Download PDFInfo
- Publication number
- CN105124088A CN105124088A CN201510434896.9A CN201510434896A CN105124088A CN 105124088 A CN105124088 A CN 105124088A CN 201510434896 A CN201510434896 A CN 201510434896A CN 105124088 A CN105124088 A CN 105124088A
- Authority
- CN
- China
- Prior art keywords
- maca
- candy
- tagatose
- agate coffee
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000000759 Lepidium meyenii Species 0.000 title claims abstract description 60
- 235000000421 Lepidium meyenii Nutrition 0.000 title claims abstract description 58
- 235000012902 lepidium meyenii Nutrition 0.000 title claims abstract description 58
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 title claims abstract description 55
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 75
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 89
- 235000016213 coffee Nutrition 0.000 claims description 88
- 235000013353 coffee beverage Nutrition 0.000 claims description 88
- 241000219780 Pueraria Species 0.000 claims description 29
- 235000013305 food Nutrition 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 12
- 235000013373 food additive Nutrition 0.000 abstract description 10
- 239000002778 food additive Substances 0.000 abstract description 10
- 230000006870 function Effects 0.000 abstract description 10
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 abstract description 9
- 239000000796 flavoring agent Substances 0.000 abstract description 9
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 abstract description 9
- 230000000968 intestinal effect Effects 0.000 abstract description 8
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 235000003599 food sweetener Nutrition 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 239000003765 sweetening agent Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 4
- 208000017667 Chronic Disease Diseases 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 210000004994 reproductive system Anatomy 0.000 abstract description 3
- 208000019331 Foodborne disease Diseases 0.000 abstract description 2
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 229960000182 blood factors Drugs 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 abstract description 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 238000005265 energy consumption Methods 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 210000002200 mouth mucosa Anatomy 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 240000007154 Coffea arabica Species 0.000 description 82
- 239000003826 tablet Substances 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 19
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 14
- 239000002994 raw material Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 229930006000 Sucrose Natural products 0.000 description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- 240000005373 Panax quinquefolius Species 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
- 206010033307 Overweight Diseases 0.000 description 5
- 239000012752 auxiliary agent Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 5
- 239000008108 microcrystalline cellulose Substances 0.000 description 5
- 239000000080 wetting agent Substances 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 239000000845 maltitol Substances 0.000 description 4
- 235000010449 maltitol Nutrition 0.000 description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 4
- 229940035436 maltitol Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000011122 softwood Substances 0.000 description 4
- 239000007916 tablet composition Substances 0.000 description 4
- 239000007910 chewable tablet Substances 0.000 description 3
- 235000019219 chocolate Nutrition 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 235000019871 vegetable fat Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 241000251511 Holothuroidea Species 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 241000609666 Tuber aestivum Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 210000003056 antler Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- -1 sorbierite Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005089 fruit drop Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002584 ketoses Chemical group 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003474 tagatoses Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a maca tablet candy containing tagatose and a Maca tablet and belongs to the field of foods. In the invention, low-temperature-pulverized Maca ultra-micro powder is composed with tagatose of which the weight ratio is 4-50% and the purity is not less than 98%. The candy is free of addition of any fruit powder, traditional Chinese herbal medicines, saccharose-series high-calorie sweetening agents, sour agent, flavoring agent, excipient and the like food additives. For regulating the taste, the candy is added with a proper amount of stachyose. The candy is easy to absorb through oral mucosa for improving reproductive system functions. The candy has the effects of conditioning intestinal micro-ecological balance, enhancing the capability of resisting digestion canal infection or food-borne diseases by human body, improving nutrition absorption and enhancing immunity. The candy can enhance key blood factors, can improve blood health of human body, has the effect of resisting oxidization, is beneficial to prevention and treatment on various chronic diseases and is beneficial to people suffered from high blood pressure, high blood fat and high blood glucose and to the elders. The candy does not cause fat deposition, is more in metabolic energy consumption, is free of decayed teeth, is suitable for people suffered from high blood fat and obesity and for women, has the effect of resisting high blood glucose and is suitable for II-type diabetic patients whom have problem in intestine canal.
Description
Technical field
The invention belongs to field of food, relate to a kind of formula making agate coffee pressed candy and Maca tablet with pueraria root powder, particularly add the agate coffee pressed candy of the compressing making of Tagatose and the formula of Maca tablet.
Background technology
At present, agate coffee (have be called agate card, card, Ma Ka etc. the) tablet such as pressed candy and numerous agate coffee buccal tablet, chewable tablets, commercially be seen everywhere, but, all there is no using function sex-health food supplement-Tagatose in the composition of raw materials of these products.Below list formula and the production firm of this type of staple on domestic market.
Kang Enbeima coffee pressed candy, list of ingredients: agate coffee, Fructus Rubi extract, lactose, wolfberry fruit extract, pueraria root powder, maltodextrin, food additives (microcrystalline cellulose, dolomol, sodium carboxymethylcellulose, polydextrose, phosphatide), Zhejiang health Kangenbei Group Co., Ltd.
Excellent grace agate coffee candy sheet, list of ingredients: grape fruit powder, pueraria root powder, food additives (D-sorbite, dolomol), the interconnected bio tech ltd of excellent grace of Shenzhen.
Precious Dubai human relations agate coffee candy sheet, list of ingredients: glucose, pueraria root powder, food additives: D-sorbite, dolomol, Bao'an branch company of Bo-hui Bio-Medical (Shenzhen) Co., Ltd..
Kind first hall agate coffee pressed candy, primary raw material: pueraria root powder, white granulated sugar, vegetable fat powder, sorbierite, microcrystalline cellulose, dolomol, taurine, Guangzhou Shan Yuantang Pharmaceutical Technology Co., Ltd.
Andes Maca tablet, main component: high-purity natural fine maca powder (purity " 98%), Yuan Zheng bio tech ltd, Kunming.
Green's perseverance letter fine maca sheet, raw material 100% agate coffee, Dongzhou Period in Chuxiong Zhou Baicao ridge medicine company Development Co., Ltd.
The smart sheet of Sa Laima card, main component: pure fine maca powder, Sa Lai bio tech ltd, Kunming.
The pole Maca tablet of Gu, primary raw material: pueraria root powder, Yunnan Guzhiji Nutriment Co., Ltd..
Profit nation Maca tablet, every hectogram contains maca powder 60g, protein 8.8g, Shenzhen Run Bang Biology Pharmacy Co., Ltd.
Product Maca tablet is good for, composition in Yunnan, south: agate coffee fine powder, dolomol, road, Yunnan derivative Technology Co., Ltd..
Perseverance is sharp reaches Maca tablet, agate coffee fine powder, dextrin, dolomol, Kunming Yuan Rui pharmaceutical Co. Ltd.
Times Si Wanmaka Yikang chewable tablets, batching: agate card, Peru Ma Ka research center Co., Ltd.
Good fortune source Maca tablet, primary raw material: pueraria root powder, maltodextrin, dolomol, Shenyang Mai Po biochemical product Co., Ltd.
Cloud GrandTech agate card essence sheet: man fills, composition: agate coffee, ginseng, Fructus lycii P.E; Ms fills: agate coffee, ginseng, kudzu-vine root powder extract; Three high dresses: agate coffee seven is had quick access to information sheet, and agate coffee, almond, kudzu-vine root powder extract, a bio tech ltd is expanded in Kunming.
Coffee fine maca sheet difficult to understand, agate coffee superfine powder, about fineness 1000 ~ 2000 order, Yunnan Ao Ka Bioisystech Co., Ltd.
Juling god's agate card, batching: fine maca powder, lactose, food additives: microcrystalline cellulose, silica, the biological Co., Ltd of Shandong Bo Aoke.
Snow power source fine maca sheet, yellow, purple pueraria root powder 98%, starch 2%; Magic power bodyguard fine maca sheet, purple, black pueraria root powder 98%, starch 2%; Sub-male fine maca sheet, yellow pueraria root powder 98%, starch 2%, Lijing is bio tech ltd everyday.
Mill at the age of one hundred years old fine maca sheet, pure natural fine maca powder, Lijing mill biotechnology development corporation, Ltd. at the age of one hundred years old.
Yun Diangao plants Maca tablet, natural quality pueraria root powder, Pu Site bio tech ltd, Yunnan.
Million Li Kangma coffee royal jelly tablets, raw material: pueraria root powder, royal jelly freeze-dried powder, Li Kang bio tech ltd, Shenzhen million.
China KeJian's space fine maca sheet, batching: pueraria root powder, Beijing Zhongke Joinyou Biotechnology Co., Ltd. produces, and Yunnan Guzhiji Nutriment Co., Ltd. produces.
Nine power unit sea cucumber Maca tablet, batching: sea cucumber, pueraria root powder, pollen pini, black tea powder etc., Weihai Nan Bowan Bioisystech Co., Ltd.
Yikang Maca tablet, agate coffee micro mist, American ginseng extract, Wuhan three and bioengineering Co., Ltd.
Agate card chewable tablets, batching: maca powder, bee pupa powder, Aspartame, dolomol, L-HPC, Bao Tianjian bio tech ltd, Kaifeng.
Match angel agate coffee pressed candy, pueraria root powder, stachyose, dolomol, Sheng Hesai angel (Beijing) International Trading Company Ltd.
Dongba horse card pressed candy, pueraria root powder, stachyose, Dongba horse card (Beijing) Science and Technology Development Co., Ltd..
Blue or green superior strong fine maca sheet, pure fine maca powder (>=99%), huge blue or green industry (Hong Kong) Co., Ltd.
U.S.'s health receives hundred special Maca Chinese yam plant quintessence composite sheet, primary raw material: Maca extract 4000mg, yam extract 50mg, cinnamomum cassia extract 20mg, pumpkin seed oil 5mg, cellulose, PowerNutritionalCo..
Japan Mingzhi Maca tablet, pueraria root powder end, food fiber (inulin), pseudo-ginseng powder, cassia bark powder, ginger powder, deodorised garlic, dietary fibre, sucrose ester, vitamin B1, vitamin B2, vitamin B6, vitamin B12 etc., Japan Mingzhi medicine Co., Ltd., Northern International Group Tianjin Medicines And Health Products Import And Export Co., Ltd is acted on behalf of.
Black マ カ 100 Maca tablet, 100% black pueraria root powder, letter business Co., Ltd. of Japan three, Tianjin Wan Defute Science and Technology Ltd. is acted on behalf of.
The content containing Tagatose is not all found from composition of raw materials disclosed in the agate coffee pressed candy of above domestic market public offering and Maca tablet commodity.
Only about the directionality report that agate coffee can be applied in food, health products, medicine field in periodical, magazine, as in the document such as article " food nutrition of agate coffee and safety evaluation and DEVELOPMENT PROSPECT " of: " food industry science and technology " Li Lei Zhou L Noboru, be showed no the related content that agate coffee pressed candy and Maca tablet add Tagatose.
About the directionality report that Tagatose can be applied at food, medicine, cosmetics, scientific research and high-technology field, as Chinese food science and technology net, 2005-02-28 " Tagatose application in the food industry "; Grain and grease magazine the 12nd phase in 2004, " D-Tag progress "; Sweetener Professional Committee of Food Additives Used in China production application TIA nd Annual Meeting compilation in 2007, is showed no the related content that Tagatose adds agate coffee pressed candy and Maca tablet in documents such as " production of Tagatose (tagatose) and application study present situations ".
Agate coffee pressed candy and Maca tablet patent document is produced with pueraria root powder, comprise as agate coffee candy, electuary, lozenge, medicinal extract, cladded type candy etc., generally contain following raw material one or more in formula: as major ingredients such as pueraria root powder, agate coffee Ultramicro-powder, agate coffee nano powder, agate coffee alcohol extract, agate coffee water extract, the residual powder of agate coffee, agate coffee preserved fruits; Add the batchings such as fruit powder, coffee, medicine-food two-purpose article, taurine, chocolate; Add candy base-material, D-sorbite, maltitol, isomalto-oligosaccharide, lactose, natural flavor or white sugar or vegetable fat powder, citric acid, the auxiliary materials such as menthe, microcrystalline cellulose, starch, pregelatinized starch.But the content be showed no in composition of raw materials containing Tagatose.
Production agate coffee candy and the main patent document of similar products are taken passages as follows:
201010160672 1 kinds of agate coffee candies, proportioning is: pueraria root powder and/or Maca extract 5%-70%, and surplus is candy base-material composition.
201110290662 Maca AN_SNple tablet and preparation method thereof: gelatinization coffee ultrasonic atomization comminuting method is pulverized, the compositions such as apple crisp slices powder, D-sorbite, maltitol, isomalto-oligosaccharide.
201220152123 1 kinds of agate coffees are chocolate: this utility model is chocolate center of inside parcel agate coffee preserved fruit.
201210333499 Maca tablet and preparation method thereof: pueraria root powder, microcrystalline cellulose, lactose, PVP, dolomol, starch are granulated, compressing tablet.
201210432133 1 kinds of agate coffee lozenges and preparation method thereof: agate coffee fresh goods wears into nanometer powder, sugar material, pregelatinized starch, acid.
201210418760 fine maca sheets and preparation method thereof: the powder process again of agate coffee Ultramicro-powder effective component extracting, batching, mixing, oven dry, compressing tablet, packaging.
201110113567 1 kinds of coffee lozenges and preparation method thereof: coffee extract, D-sorbite, maltitol, citric acid, menthe, isomalto-oligosaccharide.
Produce the main patent documents of health food such as agate coffee compressing tablet to have:
201210090742 1 kinds of health foods containing agate coffee and production technology thereof: pueraria root powder, coffee, natural flavor or white sugar or vegetable fat powder.
201210082137 agate coffee Chinese caterpillar fungus truffle health foods: Maca extract, Cordyceps, truffle fine powder, all the other are auxiliary material.
201210240620 1 kinds of agate coffees, ginseng and medlar composition and application thereof: agate coffee, ginseng, matrimony vine mixed preparing form.
02138044.9 contains health food of agate card and preparation method thereof: agate card, Chinese herbal medicine, taurine and auxiliary material.
The oral formulations (Macaandantlerforaugmentingtestosteronelevels) that US6093421 agate coffee and pilose antler are made, batching: pueraria root powder and pilose antler powder weight ratio 5: 1 to 50: 1, tablet or capsule.
PCT/US2001/049530 raises libido and the composition of Sexual potency and method (Compositionandmethodforimprovingsexualdesireandoverallse xualvitality), batching: maca extract, Shorthorned Epimedium P.E, zinc monomer thionine, aspartic acid, yogimbine extract.
All do not use Tagatose in the agate coffee candy recorded in above-mentioned all kinds of report and various documents and materials and the formula of Maca tablet, simultaneously in various degree there are following some shortcomings:
1, add auxiliary material as: the sugar contents such as agate coffee preserved fruit, candy base-material, white sugar, chocolate are high, and heat is high, be not suitable for diabetes patient, overweight people, three high persons eat;
2, maltitol is except intestinal bacterium can utilize a part, and all the other all cannot digest and excrete;
3, D-sorbite calorific value is close with sucrose, and toxicity test shows, and excessive meeting for oral administration causes diarrhoea and digestive disorders;
4, the large ability of the compound sugar consumption selected its function effective, and the function not possessing that Tagatose produces multiple health efficacy factor.
Market is needed one badly and is had regulating intestinal canal microecological balance, strengthens the Maca tablet of blood health; And do not produce carious tooth, antihyperglycemic, be suitable for diabetes patient, agate coffee pressed candy that the resultant effect such as overweight people, three high persons, the elderly, women eat is good.
Summary of the invention
The object of the invention is to overcome existing agate coffee pressed candy and and Maca tablet formula in use and easily cause carious tooth containing sweeteners such as high heat sucrose, and be unsuitable for diabetes patient, overweight people, three high persons, designed for old people, particularly do not possess regulating intestinal canal microecological balance, strengthen the deficiency of blood healthy functions, and the one provided with agate coffee Ultramicro-powder and Tagatose composite compressing, produce a kind of pueraria root powder high containing trial of strength, nutritional labeling is comprehensive, be easy to digest and assimilate, strengthen reproductive system function, develop immunitypty, there is again regulating intestinal canal microecological balance function, the Maca tablet that applicable healthy population and sub-health population eat, and produce that a kind of agate coffee content is lower, Tagatose content is higher, sugariness is moderate, promote to reduce blood sugar, promote blood healthy, better regulating intestinal canal ecological environment, do not produce carious tooth, be applicable to diabetes patient, agate coffee pressed candy that overweight people, three high persons, the elderly, women eat.
The object of the invention is to be reached by following measure:
Agate coffee pressed candy of the present invention and Maca tablet are that the functional characteristics had separately according to low-temperature grinding agate coffee Ultramicro-powder and Tagatose combines, compressing agate coffee pressed candy and Maca tablet; Do not add the batchings such as any fruit powder, Chinese herbal medicine, do not add the food additives such as sucrose high heat sweetener, acid, flavor enhancement, starch excipient.In order to adjust sugariness and the local flavor of Maca tablet and agate coffee pressed candy, it is extremely low that suitable interpolation has regulating intestinal canal colony balance, sugariness, do not produce cariogenic stachyose.
Agate coffee Ultramicro-powder fineness is: more than 2,000 order, adopts the broken technique of low-temperature submicron powder to remain agate coffee nutritional labeling comprehensively, makes again agate coffee have the high-absorbility of mucosa absorption; Namely meet the fine and smooth mouthfeel of agate coffee candy, again reduce the production cost of pueraria root powder.
Tagatose (Tagatose) a kind ofly to exist but comparatively rare natural six-carbon ketone sugar at occurring in nature, it is the ketose form of galactolipin, it is a kind of epimer of fructose, sweet taste characteristic is similar to sucrose, there is the local flavor of sucrose, and the heat produced is only 1/3rd of sucrose, be called as low calorie sweetener.
Tagatose feature:
Low in calories, zero glycemic index, the antihyperglycemic ability of Tagatose and promote the specificity of catalyst of glucokinase from nucleus to Chromosome migration, can be used for prophylactic treatment metabolic syndrome, IGT, dyslipidemia, obesity, type ii diabetes, insulin resistance disease, coronary heart disease and atherosclerotic.
The prebiotics characteristic of Tagatose, can optionally promote that growth of probiotics is bred, and favourable intestinal health also prevents colon cancer.
The antibiont membrane property of Tagatose, can be used for prevention and prohibition because of the disease in oral cavity and body caused by biofilm formation.
Tagatose can improve the characteristic of the mammalian factor, can be used for the treatment of anemia and hemophilia, promotes that blood is healthy.
The anti-oxidation characteristics of Tagatose, can be used for the many chronic diseases of prevention and therapy;
Tagatose promotes the effect that foetus health is grown can be used for the growth improving human foetus.
Tagatose is used for treating diabetes and hypoferric anemia and scurvy and has suitable curative effect.
Tagatose is applied:
For food and pharmaceutical field, there is suppression hyperglycaemia, improve the multiple physiological health effects such as gut flora, healthy blood and unlikely carious tooth.Tagatose and high sweetener are with the use of having sweet taste synergistic function.Pepsi Co. Ltd. using Tagatose as flavour enhanced dose, to improve local flavor and the mouthfeel of product.The special sweetener of sorbierite as diabetes patient can be replaced, be widely used in low sugar health care food, diet food and medical product.
Calendar year 2001, U.S. food and FAD (FDA) confirm the security of Tagatose, ratify it for GRAS product, can be used as sweetener in food beverage industry and pharmaceutical preparation.In the same year, FAO (Food and Agriculture Organization of the United Nation) and the combination food additive committee of the World Health Organization (JECFA) recommend Tagatose to be a kind of new low calorie sweetener, can use as food additives.People's Republic of China's national health and Family Planning Committee on May 30th, 2014, bulletin (2014 No. 10) the approval Tagatose about 6 kinds of new raw-food materials such as approval Tagatoses was new raw-food material.Wuxi Jcantek Pharmaceuticals Technology Co., Ltd. obtained the patent of economical production Tagatose in 2014, obtained the administrative permission of China national health State Family Planning Commission about production and operation Tagatose May 30 the same year
[.On April 1st, 2015 is starting in the 19 FIC (Chinese international food additive and the batching exhibition) whole nation, conference and exhibition center of country, Shanghai.
The U.S. specifies the scope of application of Tagatose in food and limitation:
Taffy, caramel, milk sugar, sugar cube, fruit drops, (not comprising cotton candy, jam, jelly), sugared ball and Liquoride sugar hard candy plain edition and light Wt .-loss type, add limitation 15%;
Sugar-free chewing gum, adds limitation 30%.
The present invention solves the technical scheme that its technical problem takes:
Containing the agate coffee pressed candy of Tagatose and Maca tablet composition of raw materials percentage by weight be:
Wherein: agate coffee Ultramicro-powder fineness is >=2,000 order;
Tagatose purity is >=98%.
Auxiliary agent is added in production process:
Wetting agent: purity of alcohol 90%.
Production method: dropped in mixer by the raw material in the agate coffee Ultramicro-powder of low-temperature grinding and formula and mix, add ethanol in proper amount, make softwood, softwood is granulation in granulator, with 18 order-20 eye mesh screen crushing and pelletizings; Wet granular is dried to water content 1% ~ 3% in lower than the air dry oven of 60 DEG C, adds dolomol in dried particles and make lubricant, mix, compressing tablet, plastic-aluminum cover bubble packaging.
The invention has the beneficial effects as follows: the agate coffee Ultramicro-powder made under using cryogenic conditions in agate coffee pressed candy and Maca tablet, nutritional labeling is comprehensive, fineness is suitable, be easy to buccal absorption, enhancing reproductive system function, relieve chronic muscular fatigue, mental fatigue, pressure are alleviated, delay failure of memory and have obvious facilitation.Prescription is coordinated with Tagatose, stachyose etc., can regulating intestinal canal microecological balance, strengthen the ability of human body opposing infection of digestive canal or food-borne illness, improve nutrient absorption, improve Nutritional condition of body, develop immunitypty.Also can strengthen crucial blood factor, promote that blood of human body is healthy.Simultaneously can not cause adipopexis, available energy of its release of the energy Ratios consumed in metabolic process also wants many, is more suitable for blood fat height crowd and overweight people eats.Anti-high-blood-sugar function, is particularly suitable for the in-problem type ii diabetes people of enteron aisle and eats.Anti-oxidation characteristics, is of value to the many chronic diseases of prevention and therapy, is applicable to three high crowds, designed for old people.The sweet taste of the dense local flavor of Tagatose the is soft pungent fragrance of agate coffee, taste is better, is applicable to women and eats.Adopting lozenge manufacturing technology, containing changing in mouth, can not carious tooth be caused, easy to carry and use.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment one:
Agate coffee pressed candy formula one (percentage by weight):
1, agate coffee Ultramicro-powder is preferably 49%;
2, Tagatose is preferably 30%;
3, stachyose is preferably 20%;
4, dolomol is preferably 1%.
Tagatose purity is >=98%.
Auxiliary agent is added in production process:
Wetting agent: ethanol in proper amount, purity 90%.
Production method: by formula, agate coffee Ultramicro-powder, Tagatose are dropped in V-Mixer and mix, add ethanol, make softwood, softwood is dropped in oscillating granulator and carry out granulation, with 20 eye mesh screen crushing and pelletizings; Air dry oven wet granular being placed in less than 60 DEG C is dried to water content < 3%, adds dolomol, mix in dried particles, and agate coffee pressed candy made by compressing tablet: every sheet 0.5g/ sheet, plastic-aluminum cover bubble packaging or bottled.
Embodiment two:
Agate coffee pressed candy formula two (percentage by weights):
1, agate coffee Ultramicro-powder is preferably 49%;
2, Tagatose is preferably 15%;
3, stachyose is preferably 35%;
4, dolomol is preferably 1%.
Tagatose purity is >=98%.
Auxiliary agent is added in production process:
Wetting agent: ethanol in proper amount, purity 90%.
Production method: with embodiment one.
Embodiment three:
Maca tablet formula one (percentage by weight):
1, agate coffee Ultramicro-powder is preferably 95%;
2, Tagatose is preferably 1%;
3, stachyose is preferably 0%;
4, dolomol is preferably 1%.
Tagatose purity is >=98%.
Auxiliary agent is added in production process:
Wetting agent: ethanol in proper amount, purity 90%.
Production method: with embodiment one.
Embodiment four:
Maca tablet formula two (percentage by weights):
1, agate coffee Ultramicro-powder is preferably 86%;
2, Tagatose is preferably 3%;
3, stachyose is preferably 10%;
4, dolomol is preferably 1%.
Tagatose purity is >=98%.
Auxiliary agent is added in production process:
Wetting agent: ethanol in proper amount, purity 90%.
Production method: with embodiment one.
Claims (3)
1. make a formula for agate coffee pressed candy and Maca tablet with pueraria root powder, particularly add the formula that Tagatose prepares compressing making agate coffee pressed candy and Maca tablet, it is characterized in that adding Tagatose in formula.
2. a kind of formula making agate coffee pressed candy and Maca tablet with pueraria root powder according to claim 1, particularly adds the formula that Tagatose prepares compressing making agate coffee pressed candy and Maca tablet, it is characterized in that percentage by weight is:
3. a kind of formula making agate coffee pressed candy and Maca tablet with pueraria root powder according to claim 1, particularly adds the formula that Tagatose prepares compressing making agate coffee pressed candy and Maca tablet, it is characterized in that Tagatose purity is >=98%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510434896.9A CN105124088A (en) | 2015-07-23 | 2015-07-23 | Maca tablet candy containing tagatose and Maca tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510434896.9A CN105124088A (en) | 2015-07-23 | 2015-07-23 | Maca tablet candy containing tagatose and Maca tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105124088A true CN105124088A (en) | 2015-12-09 |
Family
ID=54709970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510434896.9A Pending CN105124088A (en) | 2015-07-23 | 2015-07-23 | Maca tablet candy containing tagatose and Maca tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105124088A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109770034A (en) * | 2019-03-06 | 2019-05-21 | 深圳市旺博通科技有限公司 | A kind of production method of treasured kidney sugar |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103766571A (en) * | 2014-02-21 | 2014-05-07 | 东巴马卡(北京)科技开发有限公司 | Stachyose-containing maca tablet candy and maca tablets |
| CN104739848A (en) * | 2015-04-07 | 2015-07-01 | 福州乾正药业有限公司 | Composition containing L-arabinose and tagatose as well as preparation method and drug application of composition |
-
2015
- 2015-07-23 CN CN201510434896.9A patent/CN105124088A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103766571A (en) * | 2014-02-21 | 2014-05-07 | 东巴马卡(北京)科技开发有限公司 | Stachyose-containing maca tablet candy and maca tablets |
| CN104739848A (en) * | 2015-04-07 | 2015-07-01 | 福州乾正药业有限公司 | Composition containing L-arabinose and tagatose as well as preparation method and drug application of composition |
Non-Patent Citations (1)
| Title |
|---|
| 王成涛等: "《天然食品配料——生产及应用》", 30 June 2010 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109770034A (en) * | 2019-03-06 | 2019-05-21 | 深圳市旺博通科技有限公司 | A kind of production method of treasured kidney sugar |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN104026446A (en) | Nutritional meal replacement powder suitable for crowd with hyperglycemia and preparation method thereof | |
| CN103766571A (en) | Stachyose-containing maca tablet candy and maca tablets | |
| CN103876142B (en) | A kind of Ultramicro-powder chewable tablets with beauty treatment weight reducing effect and preparation method thereof | |
| CN104643080A (en) | Combined formula of three-day food exchange body shaping product and eating method | |
| CN103444974A (en) | Red jujube tablet candy and preparation method thereof | |
| CN101574139B (en) | Health-care food | |
| CN107048164A (en) | A kind of low sugar rice cake | |
| CN104432036A (en) | Health care nutrition composition capable of relieving asthenopia as well as preparation method and application thereof | |
| CN114128813A (en) | A kind of drink for rejuvenating and protecting liver after hangover and preparation method thereof | |
| CN101176553A (en) | Fresh fruit konjak functional food and preparation method thereof | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| CN101416743B (en) | Potentilla anserina L. rice flour food and production method thereof | |
| CN107427056A (en) | Promote natural on-off cycles of hair growth to alleviate and improve alopecia control blood glucose and alleviate and improve the healthy accesary foods of gastrointestinal disturbance | |
| CN102511616A (en) | Low-energy candy containing natural ginseng and production method thereof | |
| CN109170863A (en) | A kind of functional sugar ferment and preparation method thereof | |
| CN108272081A (en) | A kind of sea-buckthorn composite vitamin piece and preparation method thereof | |
| CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN105124088A (en) | Maca tablet candy containing tagatose and Maca tablets | |
| CN105994740A (en) | Green tea with dendrobium officinale and method for preparing green tea | |
| CN101797049B (en) | Nutrient eight-treasure soup formula and preparation process thereof | |
| CN102048134A (en) | Five-material vegetable nutraceutical and preparation method thereof | |
| CN105166620A (en) | Horseradish tree composition capable of reducing blood lipid and preparation method of horseradish tree composition | |
| CN112137112A (en) | Composite food for dispelling effects of alcohol and protecting liver and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151209 |
|
| WD01 | Invention patent application deemed withdrawn after publication |